NEU3 and COVID-19: They also showed that levels of N-acetylneuraminic acid and neuraminidase (predominantly the NEU3 isoform) were elevated in COVID-19 subjects and recovered 1 month after infection, suggesting increased desialylation in COVID-19 patients.